1. Home
  2. GDTC

GDTC

CytoMed Therapeutics Limited

Logo CytoMed Therapeutics Limited

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is majority revenue generator.

Founded: 2018 Country:
Singapore
Singapore
Employees: 27 City: N/A
Market Cap: 24.3M IPO Year: 2023
Target Price: $5.00 AVG Volume (30 days): 27.3K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.36 EPS Growth: N/A
52 Week Low/High: $1.92 - $9.25 Next Earning Date: 01-01-0001
Revenue: $573,593 Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 20.09%

Share on Social Networks: